BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12798498)

  • 1. Hormonal monitoring of ovarian activity using the Ovarian Monitor, part I. Validation of home and laboratory results obtained during ovulatory cycles by comparison with radioimmunoassay.
    Blackwell LF; Brown JB; Vigil P; Gross B; Sufi S; d'Arcangues C
    Steroids; 2003 May; 68(5):465-76. PubMed ID: 12798498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of ovarian activity by measurement of urinary excretion rates of estrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part II: reliability of home testing.
    Blackwell LF; Vigil P; Gross B; d'Arcangues C; Cooke DG; Brown JB
    Hum Reprod; 2012 Feb; 27(2):550-7. PubMed ID: 22131389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
    Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
    Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prediction and/or detection of ovulation by means of urinary steroid assays.
    Cekan SZ; Beksac MS; Wang E; Shi S; Masironi B; Landgren BM; Diczfalusy E
    Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the Home Ovarian Monitor in pregnancy avoidance.
    Brown JB; Holmes J; Barker G
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2008-11. PubMed ID: 1755460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The validation of the Billings ovulation method by laboratory research and field trials.
    Billings JJ
    Acta Eur Fertil; 1991; 22(1):9-15. PubMed ID: 1746210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of ovarian activity by measurement of urinary excretion rates using the Ovarian Monitor, Part IV: the relationship of the pregnanediol glucuronide threshold to basal body temperature and cervical mucus as markers for the beginning of the post-ovulatory infertile period.
    Blackwell LF; Vigil P; Alliende ME; Brown S; Festin M; Cooke DG
    Hum Reprod; 2016 Feb; 31(2):445-53. PubMed ID: 26677961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prototype for ovulation detection: pros and cons.
    Lasley BL; Shideler SE; Munro CJ
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2003-7. PubMed ID: 1755459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using an ovarian monitor as an adjunct to natural family planning.
    Cavero C
    J Nurse Midwifery; 1995; 40(3):269-76. PubMed ID: 7798132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
    Collins WP; Collins PO; Kilpatrick MJ; Manning PA; Pike JM; Tyler JP
    Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle.
    Stanczyk FZ; Miyakawa I; Goebelsmann U
    Am J Obstet Gynecol; 1980 Jun; 137(4):443-50. PubMed ID: 7386528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition of the potentially fertile period from urinary steroid excretion rates. Part II. A threshold value for pregnanediol glucuronide as a marker for the end of the potentially fertile period in the human menstrual cycle.
    Blackwell LF; Brown JB; Cooke D
    Steroids; 1998 Jan; 63(1):5-13. PubMed ID: 9437789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary ovarian and gonadotropin hormone levels in premenopausal women with low bone mass.
    Sowers M; Randolph JF; Crutchfield M; Jannausch ML; Shapiro B; Zhang B; La Pietra M
    J Bone Miner Res; 1998 Jul; 13(7):1191-202. PubMed ID: 9661084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of ovarian function using first morning urine steroid assays.
    Denari JH; Farinati Z; Casas PR; Oliva A
    Obstet Gynecol; 1981 Jul; 58(1):5-9. PubMed ID: 7195531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the time of ovulation in chimpanzees by measurement of LH, estrone sulfate, and pregnanediol 3 alpha-glucuronide in urine: comparison with serum hormone patterns.
    Steinetz BG; Ducrot C; Randolph C; Mahoney CJ
    J Med Primatol; 1992 Jul; 21(5):239-45. PubMed ID: 1404332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postpartum return of ovarian activity in nonbreastfeeding women monitored by urinary assays.
    Gray RH; Campbell OM; Zacur HA; Labbok MH; MacRae SL
    J Clin Endocrinol Metab; 1987 Apr; 64(4):645-50. PubMed ID: 3818896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of using paper impregnated with urine instead of liquid urine for assessing ovarian activity.
    Wasalathanthri S; Tennekoon KH; Sufi S
    Ceylon Med J; 2003 Mar; 48(1):4-6. PubMed ID: 12795010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary concentrations of steroid glucuronides in women taking oral contraceptives.
    Shaw MA; Back DJ; Aird SA; Grimmer SF; Orme MC
    Contraception; 1983 Jul; 28(1):69-75. PubMed ID: 6627945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring the menstrual cycle: Comparison of urinary and serum reproductive hormones referenced to true ovulation.
    Roos J; Johnson S; Weddell S; Godehardt E; Schiffner J; Freundl G; Gnoth C
    Eur J Contracept Reprod Health Care; 2015; 20(6):438-50. PubMed ID: 26018113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of methods for analyzing urinary steroid data to detect ovulation in athletes.
    McConnell HJ; O'Connor KA; Brindle E; Williams NI
    Med Sci Sports Exerc; 2002 Nov; 34(11):1836-44. PubMed ID: 12439091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.